logo
logo

Cardisio Gmbh Completes €3.5 Million Investment

Cardisio Gmbh Completes €3.5 Million Investment

10/19/21, 11:30 AM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/DE.svgfrankfurt
Money raised
€3.5 million
Round Type
seed
Cardisio GmbH, developers of the world's first non-invasive, highly accurate screening method for heart diseases, today announced completion of its largest investment round to date.

Company Info

Company
Cardisio Gmb H
Location
frankfurt, hesse, germany
Additional Info
Cardisio GmbH is a mobile health tech company that uses artificial intelligence in the world's first and only non-invasive screening test for coronary and structural heart diseases. The Cardisiography test is easy to administer, low cost and unprecedent in its accuracy. Cardisio GmbH is headquartered in Frankfurt, Germany, and has offices in Berlin and San Francisco. For further information, visit www.cardis.io or e-mail info@cardis.io.